Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: In vivo and in vitro studies

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 4, 2010, Pages

  Billman, George E ^a,b   Nishijima, Yoshinori ^a,b   Belevych, Andriy E ^a,b   Terentyev, Dmitry ^a,b   Xu, Ying ^a   Haizlip, Kaylan M ^a   Monasky, Michelle M ^a   Hiranandani, Nitisha ^a   Harris, William S ^c   Gyorke, Sandor ^a,b   Carnes, Cynthia A ^a,b   Janssen, Paul M L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Contractility; Diet; Force frequency relationship; Frank Starling mechanism; Heart failure; Sudden cardiac death

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM; CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID ETHYL ESTER; OMEGA 3 FATTY ACID; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DIET; DOG; ERYTHROCYTE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE FUNCTION; IN VITRO STUDY; IN VIVO STUDY; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CALCIUM; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; HEART VENTRICLES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; VENTRICULAR FUNCTION, LEFT;

EID: 77949706505     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01065.2009     Document Type: Article

References (70)

1. Albert CM, Campos H, Stampfer MJ, Ridker PM, Mason JE, Willet WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 1113-1118, 2002.
2. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in northwestern Greenland. Am J Clin Nutr 33: 2657-2661, 1980.
3. Billman GE. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. Pharmacol Ther 111: 808-835, 2006.
4. Billman GE. Cardiac autonomic neural "remodeling" and susceptibility to sudden cardiac death: effect of endurance exercise training. Am J Physiol Heart Circ Physiol 297: H1171-H1193, 2009.
5. Billman GE, Dujardin J. Dynamic changes in cardiac vagal tone as measured by time-series analysis. Am J Physiol Heart Circ Physiol 258: H896-H902, 1990.
6. Billman GE, Kukielka M. Effect of exercise training on heart rate variability and susceptibility to sudden cardiac death: protection is not due to enhanced cardiac vagal regulation. J Appl Physiol 100: 896-906, 2006.
7. Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega-3 fatty acids. Proc Natl Acad Sci USA 91: 4427-4430, 1994.
8. Billman GE, Schwartz PJ, Gagnol JP, Stone HL. The cardiac response to submaximal exercise in dogs susceptible to sudden cardiac death. J Appl Physiol 59: 890-897, 1985.
9. 2-adrenoceptor responsiveness and prevents ventricular fibrillation in animals susceptible to sudden death. Am J Physiol Heart Circ Physiol 290: H2590-H2599, 2006.
10. Bligh EG, Dyer WJ. A rapid method for total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
11. Boden WE, Krone RJ, Kleiger RE, Oakes D, Greenberg H, Dwyer EJ Jr, Miller JP, Abrams J, Coromilas J, Goldstein R. Electrocardiographic subset analysis of diltiazem on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group. Am J Cardiol 63: 70-79, 1991.
12. Brouwer IA, Riatt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, Katan MB, Connor WE, Camm JA, Schouten EG, McAnulty J. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J 30: 820-826, 2009.
13. Burr ML, Dunstan FD, George CH. Is fish oil good or bad for heart disease? Two trials with apparently conflicting results. J Membr Biol 206: 155-163, 2005.
14. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2: 757-761, 1989.
15. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA, Elwood PC. Lack of benefit of dietary advice to men with angina: results of controlled trial. Eur J Clin Nutr 57: 193-200, 2003.
16. Christensen JH, Gustenhoff P, Korup E, Aaroe J, Toft E, Moller J, Rasmussen K, Dyerberg J, Schmidt EB. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomized controlled study. Br Med J 312: 677-678, 1996.
17. Dallongeville J, Yarnell J, Ducimetiere P, Arveiler D, Ferrieres J, Montaye M, Luc G, Evans A, Bingham A, Haas B, Ruidavets JB, Amouyel P. Fish consumption is associated with lower heart rates. Circulation 108: 820-825, 2003.
18. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, Walsh MK, Morris D, Shekelle RB. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 336: 1046-1053, 1997.
19. Den Ruijter HM, Berecki G, Verkerk AO, Bakker D, Baartscheer A, Schumacher CA, Belterman CN, de Jonge N, Fiolet JW, Brouwer IA, Coroanel R. Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation 117: 536-544, 2008.
20. Di Stasi D, Bernasconi R, Marchioli R, Marfisi RM, Rossi G, Tognoni G, Tacconi MT. Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids. Eur J Clin Pharmacol 60: 183-190, 2004.
21. Duda MK, O'Shea KM, Lei B, Barrows BR, Azimzadeh AM, McElfresh TE, Hoit BD, Kop WJ, Stanley WC. Dietary supplementation with ω-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 76: 303-310, 2007.
22. Duda MK, O'Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, Chess DJ, Azimzadeh AM, Harris WS, Sharon VG, Sabbah HN, Stanley WC. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 81: 319-327, 2009.
23. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2: 117-119, 1978.
24. 2+ current in adult cardiac myocytes. Cardiovasc Res 54: 601-610, 2002.
25. Geelen A, Zock PL, Swenne CA, Brouwer IA, Schouten EG, Katan MB. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. Am Heart J 146: E4, 2003.
26. Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372: 1223-1230, 2008.
27. Hamaad A, Kaeng Lee W, Lip GY, MacFadyen RJ. Oral omega-3 PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients. Cardiovasc Drug Ther 20: 359-364, 2006.
28. Hanson JF. Treatment with verapamil during and after acute myocardial infarction: a review based upon the Danish verapamil infarction trials I and II. J Cardiovasc Pharmacol 19, Suppl 6: S20-S25, 1991.
29. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39: 212-220, 2004.
30. Harris WS, Gonzles M, Laney N, Sastre A, Borkon AM. Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. Am J Cardiol 98: 1393-1395, 2006.
31. Harris WS, DiRienzo MA, Sands SA, George C, Jones PG, Eapen AK. Stearidonic acid increases red blood cell and heart EPA content in dogs. Lipids 42: 325-333, 2007.
32. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 110: 1645-1649, 2004.
33. 2+ current in guinea-pig tracheal smooth muscle cells. Eur J Pharmacol 355: 257-266, 1998.
34. Honen BN, Saint DA, Laver DR. Suppression of calcium sparks in rat ventricular myocytes and direct inhibition of sheep cardiac RyR channels by EPA, DHA and oleic acid. J Membr Biol 196: 95-103, 2003.
35. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, Durrington PN, Ness AR, Capps NE, Davey Smith G, Riemersma RA, Ebrahim SB. Omega-3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 4: CD003177, 2004.
36. Houle MS, Altschuld RA, Billman GE. Enhanced in vivo and in vitro responses with β2-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias. J Appl Physiol 91: 1627-1637, 2001.
37. Kris-Etherton PM, Harris WS, Appel LJ; AHA Nutrition Committee. American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 23: 151-152, 2003.
38. Kromhout D, Bosschieter EB, de Lezenne CC. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312: 1205-1209, 1985.
39. León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. Br Med J 338: a2931, 2009.
40. Li GR, Du XL, Siow YL, O K, Tse HF, Lau CP. Calcium-activated transient outward chloride current and phase 1 repolarization of swine ventricular action potential. Cardiovasc Res 58: 89-98, 2003.
41. London B, Albert C, Anderson ME, Giles WR, Van Wagoner DR, Balk E, Billman GE, Chung M, Lands W, Leaf A, McAnulty J, Martens JR, Costello RB, Lathrop DA. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation 116: e320-e335, 2007.
42. Lortet S, Verger P. Alteration of cardiovascular function in trained rats fed fish oil. Int J Sports Med 16: 519-521, 1995.
43. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Martini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F, GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105: 1897-1903, 2002.
44. McLennan PL, Barnden LR, Bridle TM, Abeywardena MY, Charnock JS. Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc Res 26: 871-877, 1992.
45. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5: 600-608, 1964.
46. Mozaffarian D, Prineas RJ, Stein PK, Siscovik DS. Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol 48: 478-484, 2006.
47. Mozaffarian D, Stein PK, Prineas RJ, Siscovick DS. Dietary Fish ω-3 fatty acid consumption and heart rate variability in US adults. Circulation 117: 1130-1137, 2008.
48. Mozaffarian D, Geelen A, Brouwer IA, Geleijinse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: meta-analysis of randomized controlled trials. Circulation 112: 1945-1952, 2005.
49. Negretti N, Perez MR, Walker D, O'Neill SC. Inhibition of sarcoplasmic reticulum by polyunsaturated fatty acids in intact, isolated myocytes from rat ventricular muscle. J Physiol 523: 367-375, 2000.
50. O'Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fraction. Am J Cardiol 97: 1127-1130, 2006.
51. Olgar S, Ertugrul T, Nisli K, Omeroglu RE, Dindar A, Aydogan U. Fish oil supplementation improves left ventricular function in children with idiopathic dilated cardiomyopathy. Congest Heart Fail 13: 308-312, 2007.
52. O'Neill SC, Perez MR, Hammond KE, Sheader EA, Negretti N. Direct and indirect modulation of rat cardiac sarcoplasmic reticulum function by n-3 polyunsaturated fatty acids. J Physiol 538: 179-184, 2002.
53. Parati G, di Rienzo M, Castiglioni P, Mancia G, Taylor JA, Studinger P. Point: Counterpoint: Cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol 101: 676-682, 2006.
54. Porges SW. Respiratory sinus arrhythmia: physiological basis, quantitative methods and clinical implications. In: Cardiac, Respiratory, and Cardiosomatic Psychophysiology. New York: Plenum, 1986, p. 101-115.
55. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, Salonen JT. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 102: 2677-2679, 2000.
56. Sakabe M, Shiroshita-Takeshita A, Maguey A, Dumesnil C, Nigam A, Leung TK, Nattel S. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation 116: 2101-2109, 2007.
57. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH, Cobb LA, Copass MK, Psaty BM, Lemaitre R, Retzlaff B, Childs M, Knopp R. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274: 1363-1367, 1995.
58. Skou HA, Toft E, Christensen JH, Hansen JB, Dyerberg J, Schmidt EB. N-3 fatty acids and cardiac function after myocardial infarction in Denmark. Int J Circumpolar Health 60: 360-365, 2001.
59. Sridhar A, Nishijima Y, Terentyev D, Terentyeva R, Uelman R, Kukielka M, Bonilla IM, Robertson GA, Gyorke S, Billman GE, Carnes CA. Repolarization abnormalities and afterdepolarizations in a canine model of sudden cardiac death. Am J Physiol Regul Integr Comp Physiol 295: R1463-R1472, 2008.
60. 2+-release and ryanodine receptor function. Cardiovasc Res 60: 337-346, 2003.
61. Takahashi R, Okumura K, Asai T, Hirai T, Murakami H, Murakami R, Numaguchi Y, Matsui H, Ito M, Murohara T. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res 68: 213-223, 2005.
62. Task Force of the European Society of Cardiology, and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93: 1043-1065, 1996.
63. Varian KD, Janssen PM. Frequency-dependent acceleration of relaxation involves decreased myofilament calcium sensitivity. Am J Physiol Heart Circ Physiol 292: H2212-H2219, 2007.
64. Verkerk AO, van Ginneken AC, Berecki G, Den Ruijter HM, Schumacher CA, Veldkamp MW, Baartscheer A, Casini S, Opthof T, Hovenier R, Fiolet JW, Zock PL, Coronel R. Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials in pigs. Cardiovasc Res 70: 509-520, 2006.
65. Verkerk AO, den Ruijter HM, Bourier J, Boukens BJ, Brouwer IA, Wilders R, Coronel R. Dietary fish oil reduces pacemaker current and heart rate in rabbit. Heart Rhythm 6: 1485-1492, 2009.
66. von Schacky C, Harris WS. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73: 310-315, 2007.
67. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 94: 4182-4187, 1997.
68. Yang BC, Saldeen TG, Bryant JL, Nichols WW, Mehta JL. Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. Am Heart J 126: 1287-1292, 1993.
69. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolemic (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369: 1090-1098, 2007.
70. Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: meta-analysis of randomized controlled trials. Ann Med 41: 301-310, 2009.